Document is current
Any future updates will be listed below
-
Authors
Gampenrieder, Simon Peter https://orcid.org/0000-0002-3966-1071
- License Information
-
More Information
Article History
Received: 22 June 2020
Accepted: 25 June 2020
First Online: 21 September 2020
Conflict of interest
: S.P. Gampenrieder: Employment: none; Leadership: none; Stock or other Ownership: none; Honoraria: Novartis, Roche, BMS, AstraZeneca, MSD; Consulting or Advisory Role: Roche, Novartis,<sup>,</sup> Pfizer, Lilly, AstraZeneca, MSD; Speakers Bureau: none; Research Funding: Roche; Patents, Royalties or Other Intellectual Property: none; Expert Testimony: none; Travel, Accommodation, Expenses: Roche, Amgen, Shire, Novartis, Pfizer, Bayer, Celgene, Daiichi Sanky; Other Relationships: none.
Free to read: This content has been made available to all.
